Genomic Data Protection Act
The source supplies the latest action, but no lifecycle stage.
Latest action (5 Mar 2025): Read twice and referred to the Committee on Commerce, Science, and Transportation.
What this bill does
The Genomic Data Protection Act would require direct-to-consumer genomic testing companies—such as firms offering at-home DNA testing kits—to give consumers a simple way to access their genomic data, delete their account and associated data, and request destruction of their biological sample. Companies would have to clearly disclose these rights and note that deidentified genomic data may be shared for medical or scientific research. Requests to delete data or destroy samples would generally need to be fulfilled, and consumers notified, within 30 days, though companies could refuse if deletion would violate a court order or another legal requirement. If a company is bought or acquired, it must notify consumers at least 30 days beforehand, and the new owner must honor any pending deletion requests.
The bill primarily affects consumers who submit biological samples to direct-to-consumer genomic testing companies and the companies themselves, which would face new disclosure and data-handling obligations. Health care professionals performing genomic analysis for diagnosis or treatment are excluded from the definition of covered companies. Violations would be enforced by the Federal Trade Commission as unfair or deceptive practices, and the FTC could issue implementing rules within a year of enactment. The bill would not preempt state laws except where they directly conflict with its provisions.
The bill was introduced in the Senate on March 5, 2025, by Senator Bill Cassidy with Senator Peters, and referred to the Committee on Commerce, Science, and Transportation. It has not yet been voted on, and further committee action or amendment would be needed before it could advance.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
5 Mar 2025
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Common questions
- What does S. 863 do?
- The Genomic Data Protection Act would require direct-to-consumer genomic testing companies—such as firms offering at-home DNA testing kits—to give consumers a simple way to access their genomic data, delete their account and associated data, and request destruction of their biological sample. Companies would have to clearly disclose these rights and note that deidentified genomic data may be shared for medical or scientific research. Requests to delete data or destroy samples would generally need to be fulfilled, and consumers notified, within 30 days, though companies could refuse if deletion would violate a court order or another legal requirement. If a company is bought or acquired, it must notify consumers at least 30 days beforehand, and the new owner must honor any pending deletion requests. The bill primarily affects consumers who submit biological samples to direct-to-consumer genomic testing companies and the companies themselves, which would face new disclosure and data-handling obligations. Health care professionals performing genomic analysis for diagnosis or treatment are excluded from the definition of covered companies. Violations would be enforced by the Federal Trade Commission as unfair or deceptive practices, and the FTC could issue implementing rules within a year of enactment. The bill would not preempt state laws except where they directly conflict with its provisions. The bill was introduced in the Senate on March 5, 2025, by Senator Bill Cassidy with Senator Peters, and referred to the Committee on Commerce, Science, and Transportation. It has not yet been voted on, and further committee action or amendment would be needed before it could advance.
- Has S. 863 become law?
- The source does not supply a confirmed lifecycle stage for S. 863. Check the latest action and official source below.
- Who sponsored S. 863?
- S. 863 was sponsored by Sen. Cassidy, Bill [R-LA] (R-LA), with 1 cosponsor.
- What's the latest action on S. 863?
- Read twice and referred to the Committee on Commerce, Science, and Transportation. (5 Mar 2025).
Related bills in Commerce
Critical Infrastructure Manufacturing Feasibility Act
Cybersecurity for Small Businesses Act of 2026
Combating Foreign Threats to Main Street Act of 2026
Small Business Payment for Performance Act of 2026
More bills from Sen. Cassidy, Bill [R-LA]
Domestic Manufacturing Revitalization Act of 2026
Taxpayer Funded Compensation Accountability Act
Safe and Fair Elections Act of 2026
A bill to amend the Internal Revenue Code of 1986 to eliminate the State opt-in requirement for the qualified elementary and secondary education scholarship credit.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.